| Literature DB >> 36092630 |
Octavio Calvo-Gomez1, Hiram Calvo2, Leticia Cedillo-Barrón3, Héctor Vivanco-Cid4, Juan Manuel Alvarado-Orozco5, David Andrés Fernandez-Benavides5, Lourdes Arriaga-Pizano6, Eduardo Ferat-Osorio6, Juan Carlos Anda-Garay6, Constantino López-Macias6, Mercedes G López1.
Abstract
The COVID-19 pandemic has caused major disturbances to human health and economy on a global scale. Although vaccination campaigns and important advances in treatments have been developed, an early diagnosis is still crucial. While PCR is the golden standard for diagnosing SARS-CoV-2 infection, rapid and low-cost techniques such as ATR-FTIR followed by multivariate analyses, where dimensions are reduced for obtaining valuable information from highly complex data sets, have been investigated. Most dimensionality reduction techniques attempt to discriminate and create new combinations of attributes prior to the classification stage; thus, the user needs to optimize a wealth of parameters before reaching reliable and valid outcomes. In this work, we developed a method for evaluating SARS-CoV-2 infection and COVID-19 disease severity on infrared spectra of sera, based on a rather simple feature selection technique (correlation-based feature subset selection). Dengue infection was also evaluated for assessing whether selectivity toward a different virus was possible with the same algorithm, although independent models were built for both viruses. High sensitivity (94.55%) and high specificity (98.44%) were obtained for assessing SARS-CoV-2 infection with our model; for severe COVID-19 disease classification, sensitivity is 70.97% and specificity is 94.95%; for mild disease classification, sensitivity is 33.33% and specificity is 94.64%; and for dengue infection assessment, sensitivity is 84.27% and specificity is 94.64%.Entities:
Year: 2022 PMID: 36092630 PMCID: PMC9453986 DOI: 10.1021/acsomega.2c01374
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Average of all 55 SARS-CoV-2 positive spectra, and the average of all 194 negatives (cm–1). Wavenumbers selected for separation of categories between both types of samples indicated by vertical lines.
Wavenumbers Selected by Our Model for Separation in Categories between SARS-CoV-2 Infected and Non-infected Patients (cm–1)
| 1018.23 | 1045.22 | 1054.87 | 1079.94 | 1643.05 |
| 1024.01 | 1047.15 | 1068.37 | 1116.58 | 1646.91 |
| 1025.94 | 1049.08 | 1070.29 | 1135.86 | 1751.04 |
| 1027.87 | 1051.01 | 1076.08 | 1159.00 | 1752.97 |
| 1035.58 | 1052.94 | 1078.01 | 1536.98 | 2923.55 |
Figure 22D representation of Y1/CS1 scores by PLS-DA of SARS-CoV-2 infected and non-infected patients.
Maximum Bands of Cytokine Standards Wavelengths vs SARS-CoV-2 Contagion Selected Wavelengths (cm–1)
| IP-10 | VEGF | IL-6 | IL-2 | IFN-γ | IL-1α | IL-1 | IL-1β | TNF-α | IL-17 | selected λ |
|---|---|---|---|---|---|---|---|---|---|---|
| 1069 | 1068, 1070 | |||||||||
| 1117 | 1117 | |||||||||
| 1076 | 1076 | 1077 | 1076, 1078 | |||||||
| 1080 | 1080 | |||||||||
| 1538 | 1538 | 1542 | 1542 | 1540 | 1536 | 1537 | ||||
| 1644 | 1643 | 1642 | 1642 | 1641 | 1643 | |||||
| 1648 | 1649 | 1648 | 1649 | 1646 | 1647 |
Figure 3Raw spectra of cytokine standards where correspondence with our model was shown (in absorbance vs wavenumber range in cm–1).
Confusion Matrix for SARS-CoV-2 Infection Status Instances Classification
| cohorts | non-infected | SARS-CoV-2 infected |
|---|---|---|
| negatives | 190 | 4 |
| positives | 3 | 52 |
Evaluation Matrix for SARS-CoV-2 Infection Status Classification
| class | precision | recall | F-measure | MCC | ROC area | PRC area |
|---|---|---|---|---|---|---|
| non-infected | 0.984 | 0.979 | 0.982 | 0.919 | 0.949 | 0.962 |
| infected | 0.929 | 0.945 | 0.937 | 0.919 | 0.895 | 0.488 |
| weighted average | 0.972 | 0.972 | 0.972 | 0.919 | 0.937 | 0.858 |
Distribution of Cases
| severity | cases |
|---|---|
| not infected | 194 |
| unknown | 12 |
| high | 31 |
| mild | 12 |
Wavenumbers Selected by Our Model for Assessing COVID-19 Disease Severity (cm–1)
| 1014.37 | 1051.01 | 1083.79 | 2792.42 |
| 1031.72 | 1052.94 | 1646.91 | 2923.55 |
| 1039.44 | 1054.87 | 1756.83 | |
| 1049.08 | 1064.51 | 2391.29 |
Confusion Matrix for COVID-19 Disease Severity
| classification
according to model | ||||
|---|---|---|---|---|
| cohorts (according to clinical history) | not infected | unknown | severe | mild |
| not infected | 186 | 2 | 1 | 5 |
| severity unknown | 2 | 0 | 8 | 2 |
| severe | 1 | 3 | 22 | 5 |
| mild | 4 | 2 | 2 | 4 |
Wavenumbers Selected by Our Model for Separation in Categories between Dengue Infected and Non-infected Patients (cm–1)
| 1008.58 | 1556.27 | 2285.23 | 2902.34 |
| 1012.44 | 1558.20 | 2289.09 | 2925.48 |
| 1024.01 | 1724.04 | 2387.44 | 3394.10 |
| 1351.85 | 1725.97 | 2389.37 | 3561.87 |
| 1365.35 | 1754.90 | 2391.29 | 3727.72 |
| 1554.34 | 2273.66 | 2412.51 | 3789.43 |
Confusion Matrix for Dengue Infection Status Instances Classification
| classification
according to model | ||
|---|---|---|
| cohorts | non-infected | infected with dengue |
| non-infected | 233 | 14 |
| infected with dengue | 14 | 61 |
Evaluation Matrix for Dengue Infection Status Classification
| class | precision | recall | MCC | ROC area | PRC area | |
|---|---|---|---|---|---|---|
| non-infected | 0.936 | 0.943 | 0.940 | 0.737 | 0.943 | 0.982 |
| infected | 0.808 | 0.787 | 0.797 | 0.737 | 0.943 | 0.858 |
| weighted average | 0.913 | 0.913 | 0.913 | 0.737 | 0.943 | 0.953 |